Healthcare

Accelerating Healthcare: Drug Diversion Surveillance

While the Covid-19 pandemic continues to dominate the news, coverage of America’s “other” health crisis -- the opioid epidemic -- has fallen off the front page, even as the damage and death it’s bringing to our country grows. In the 12 months ending in May 2020, the Centers for Disease Control and Prevention recorded more than 81,000 overdose deaths -- the most ever recorded in a 12-month period by the Centers.

• Read more about Accelerating Healthcare: Drug Diversion Surveillance

Five Questions Every Pharmacy Manager Should Ask About Physical Inventory

Pharmacy physical inventory is a critical but sometimes disruptive process within the healthcare system. But getting an accurate on-hand product count doesn’t have to interfere with everyday pharmacy operations. By engaging proven experts and asking the right questions, pharmacy managers can identify the best options available for driving improved inventory efficiency in support of greater profitability. So, here are five questions that pharmacy managers should ask to make sure they’re getting the professional inventory services they need -- and should expect. 

• Read more about Five Questions Every Pharmacy Manager Should Ask About Physical Inventory

INMAR INTELLIGENCE HOSTED DRUG DISPOSAL DRIVE-THRU EVENT AT WINSTON-SALEM HEADQUARTERS

Inmar Intelligence, in support of the DEA’s most recent National Prescription Drug Take-Back Day, hosted a consumer drug take-back event on October 24 at its Team Support Center in the Winston-Salem Innovation Quarter.  The drive-thru drug drop off was a collaboration between Inmar, the DEA, the State Bureau of Investigation and the Winston-Salem Police Department, enabling members of the community to safely and conveniently remain in their vehicles while disposing of unneeded medications.

• Read more about INMAR INTELLIGENCE HOSTED DRUG DISPOSAL DRIVE-THRU EVENT AT WINSTON-SALEM HEADQUARTERS

The Business of Pharmacy

The United States spends almost twice as much per capita on healthcare versus other developed countries. This level of expenditure is driving disruption -- which is occurring on many fronts, including reformation of retail pharmacy models. While COVID-19 created a catalyst for change, and clearly demonstrated the importance that retail pharmacies play in the healthcare ecosystem, the long-term viability of traditional models continues to be challenged.

• Read more about The Business of Pharmacy

2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers

In light of the disruption brought to the pharmaceutical industry by the COVID-19 pandemic, the FDA recently issued updated guidance regarding its enforcement of key DSCSA verification requirements. As a service to the industry, Dwight de Vera, our General Manager, Healthcare Intelligence Solutions, provides a brief but insightful analysis of the FDA’s latest action in the video below.

• Read more about 2020 DSCSA Regulatory Update Verification for Pharmacies and Wholesalers

DSCSA Mini-Panel: Counterfeit Mitigation

Maintaining patient safety -- through the mitigation of counterfeit medications -- is getting a boost as systemic protective measures are quickly coming online throughout the healthcare ecosystem. However, while serialization will eventually enable the validation of saleable products, the threat to public health from fraudulent drugs has hardly disappeared. Watch this video with industry experts from Inmar for a brief take on the current situation.

• Read more about DSCSA Mini-Panel: Counterfeit Mitigation

DSCSA Mini-Panel: Inventory Accuracy

Optimizing pharmaceutical inventory accuracy isn’t about making best use of storage space. It’s critical, and often complex, asset management that’s essential to maintaining both efficient operations and regulatory compliance. Get a quick, fresh perspective on this important healthcare business function in this video featuring industry experts from Inmar.

• Read more about DSCSA Mini-Panel: Inventory Accuracy

DSCSA Mini-Panel: Recall Management

Drug recalls, as often as they occur, are not “business-as-usual” for stakeholders in the healthcare ecosystem. Pharma manufacturers, retail pharmacies and health systems each face unique challenges with every market action -- and each require individualized assistance in responding. Check out this video to get the “topline” on recall requirements and the help available from Inmar’s experts.  

• Read more about DSCSA Mini-Panel: Recall Management

What Pharma Manufacturers Need to Know about Consumer Drug Take-Back

As jurisdictions across the U.S. continue implementing and enforcing disparate legislation mandating drug take-back programs, the burden of funding and execution for these programs has fallen upon pharmaceutical manufacturers. 

• Read more about What Pharma Manufacturers Need to Know about Consumer Drug Take-Back